(Q24535988)

English

Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Spotswood L Spruance

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Robert Nett

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Thomas Marbury

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Ray Wolff

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

James Johnson

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Theodore Spaulding

6

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

2238-2243

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and efficacy of different topical formulations against cutaneous herpes simplex virus infections in guinea pigs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Successful treatment of herpes labialis with topical acyclovir.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Failure of acyclovir cream in treatment of recurrent herpes labialis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Failure of topical acyclovir in ointment to penetrate human skin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

27 September 2017

Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Natural History And Topical Acyclovir Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

30 May 2018

Herpes labialis treatment with acyclovir 5 per cent ointment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

30 May 2018

Treatment of recurrent herpes simplex labialis with oral acyclovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

30 May 2018

Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127288

29 November 2018

Topical acyclovir in the management of recurrent herpes labialis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12069980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of recurrent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12069980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-herpetic erythema multiforme prevented with prophylactic oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/12069980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12069980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12069980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.46.7.2238-2243.2002

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

release_myphx57bj5bpxfbmfcwhduft7m

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24535988&oldid=1953402300"